Serum GADD45a methylation is a useful biomarker to distinguish benign vs malignant prostate disease
Crossref DOI link: https://doi.org/10.1038/bjc.2015.240
Published Online: 2015-07-14
Published Print: 2015-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Reis, I M
Ramachandran, K
Speer, C
Gordian, E
Singal, R
Text and Data Mining valid from 2015-07-01
Article History
Received: 25 March 2015
Revised: 22 May 2015
Accepted: 9 June 2015
First Online: 14 July 2015
Competing interests
: The authors declare no conflict of interest.